Synageva BioPharma (GEVA) Commences $80 Million Common Stock Offering
Tweet Send to a FriendGet Alerts GEVA Hot Sheet
Down)
Trade GEVA Now!
Synageva BioPharma (NASDAQ: GEVA) has commenced a $80 million underwritten public offering of shares of its common stock.
In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock to cover over-allotments, if any, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley (NYSE: MS) and J.P. Morgan (NYSE: JPM) are acting as joint book-running managers in the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock to cover over-allotments, if any, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley (NYSE: MS) and J.P. Morgan (NYSE: JPM) are acting as joint book-running managers in the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Galena Biopharma (GALE) Registers 10.77M Shares Tied to Warrants
- Baltic Trading (BALT) Announces Stock Offering
- GasLog (GLOG) Files $500M Mixed Securities Shelf
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
